Biotech Values

[srsmgja]

Not a word in the press release regarding UNIT SALES of copaxone. I wonder why that detail was left out? Perhaps they'll mention it on the conference call.

I still contend that the overwhelming majority of this sales increase is due to the 30% YEARLY increases over the last 3 years. These price increases are not sustainable, IMO